Document Detail

Outcomes using lower vs higher hemoglobin thresholds for red blood cell transfusion.
MedLine Citation:
PMID:  23280228     Owner:  NLM     Status:  PubMed-not-MEDLINE    
CLINICAL QUESTION: Is a lower vs higher hemoglobin threshold best for minimizing both red blood cell use and adverse clinical outcomes when used to trigger red blood cell transfusions in anemic patients in critical care and acute care settings?
BOTTOM LINE: Compared with higher hemoglobin thresholds, a hemoglobin threshold of 7 or 8 g/dL is associated with fewer red blood cell units transfused without adverse associations with mortality, cardiac morbidity, functional recovery, or length of hospital stay.
Jeffrey L Carson; Paul A Carless; Paul C Hébert
Related Documents :
15313948 - Laminar flow activates peroxisome proliferator-activated receptor-gamma in vascular end...
3888058 - Venous thrombogenesis.
17890948 - Monitoring fondaparinux with the sonoclot.
8614068 - Hemodynamic and fibrinolytic consequences of intermittent pneumatic compression: prelim...
2681598 - Myogenic mechanisms in the cerebral circulation.
9407288 - Measurements of airway dimensions and calculation of mass transfer characteristics of t...
Publication Detail:
Type:  Comment; Journal Article    
Journal Detail:
Title:  JAMA     Volume:  309     ISSN:  1538-3598     ISO Abbreviation:  JAMA     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-01-02     Completed Date:  2013-01-03     Revised Date:  2014-09-17    
Medline Journal Info:
Nlm Unique ID:  7501160     Medline TA:  JAMA     Country:  United States    
Other Details:
Languages:  eng     Pagination:  83-4     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Comment On:
Cochrane Database Syst Rev. 2012;4:CD002042   [PMID:  22513904 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Association of all-cause mortality with overweight and obesity using standard body mass index catego...
Next Document:  Presence and role of anti-citrullinated protein antibodies in experimental arthritis models.